A randomized phase III trial of personalized peptide vaccination for castration‑resistant prostate cancer progressing after docetaxel

Author:

Noguchi Masanori1ORCID,Fujimoto Kiyohide2,Arai Gaku3,Uemura Hiroji4,Hashine Katsuyoshi5,Matsumoto Hiroaki6,Fukasawa Satoshi7,Kohjimoto Yasuo8,Nakatsu Hideomi9,Takenaka Atsushi10,Fujisawa Masato11,Uemura Hirotsugu12,Naito Seiji13,Egawa Shin14,Fujimoto Hiroyuki15,Hinotsu Shiro16,Itoh Kyogo1

Affiliation:

1. Cancer Vaccine Center and Department of Urology, Kurume University, Kurume, Fukuoka 839‑0863, Japan

2. Department of Urology, Nara Medical University Hospital, Kashihara, Nara 634‑8522, Japan

3. Department of Urology, Dokkyo Medical University Saitama Medical Center, Koshigaya, Saitama 343‑8555, Japan

4. Department of Urology, Yokohama City University Medical Center, Yokohama, Kanagawa 232‑0024, Japan

5. Department of Urology, Shikoku Cancer Center, Matsuyama, Ehime 791‑0280, Japan

6. Department of Urology, Yamaguchi University Hospital, Ube, Yamaguchi 755‑8505, Japan

7. Department of Urology, Chiba Cancer Center, Chiba, Chiba 260‑8717, Japan

8. Department of Urology, Wakayama Medical University Hospital, Wakayama, Wakayama 641‑8510, Japan

9. Department of Urology, Asahi General Hospital, Asahi, Chiba 289‑2511, Japan

10. Department of Urology, Tottori University Hospital, Yonago, Tottori 683‑8504, Japan

11. Department of Urology, Kobe University Hospital, Kobe, Hyogo 650‑0017, Japan

12. Department of Urology, Kindai University Hospital, Sayama, Osaka 589‑8511, Japan

13. Department of Urology, Sanshinkai Hara Hospital, Fukuoka, Fukuoka 812‑0033, Japan

14. Department of Urology, The Jikei University Hospital, Minatoku, Tokyo 105‑8471, Japan

15. Department of Urology, National Cancer Center Hospital, Chyuoku, Tokyo 104‑0045, Japan

16. Department of Urology, Sapporo Medical University, Sapporo, Hokkaido 060‑8543, Japan

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology,General Medicine

Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3